A detailed history of Fifth Third Bancorp transactions in Exact Sciences Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 319 shares of EXAS stock, worth $18,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
319
Previous 246 29.67%
Holding current value
$18,336
Previous $10,000 110.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$42.43 - $70.83 $3,097 - $5,170
73 Added 29.67%
319 $21,000
Q2 2024

Jul 22, 2024

SELL
$41.33 - $74.26 $82 - $148
-2 Reduced 0.81%
246 $10,000
Q1 2024

Apr 23, 2024

BUY
$56.27 - $73.77 $618 - $811
11 Added 4.64%
248 $17,000
Q3 2023

Oct 31, 2023

SELL
$65.94 - $99.04 $1,252 - $1,881
-19 Reduced 7.42%
237 $16,000
Q2 2023

Jul 25, 2023

BUY
$62.68 - $95.05 $1,190 - $1,805
19 Added 8.02%
256 $24,000
Q1 2023

Apr 24, 2023

BUY
$47.19 - $70.77 $1,746 - $2,618
37 Added 18.5%
237 $16,000
Q4 2022

Jan 25, 2023

SELL
$30.35 - $53.15 $7,284 - $12,756
-240 Reduced 54.55%
200 $0
Q3 2022

Oct 25, 2022

BUY
$31.97 - $49.37 $191 - $296
6 Added 1.38%
440 $14,000
Q2 2022

Aug 04, 2022

SELL
$35.61 - $76.23 $4,700 - $10,062
-132 Reduced 23.32%
434 $17,000
Q1 2022

Apr 19, 2022

BUY
$57.56 - $82.54 $4,892 - $7,015
85 Added 17.67%
566 $40,000
Q4 2021

Feb 01, 2022

SELL
$72.5 - $100.68 $4,350 - $6,040
-60 Reduced 11.09%
481 $37,000
Q3 2021

Oct 15, 2021

BUY
$90.24 - $124.05 $1,714 - $2,356
19 Added 3.64%
541 $52,000
Q2 2021

Aug 06, 2021

SELL
$93.66 - $139.27 $17,514 - $26,043
-187 Reduced 26.38%
522 $65,000
Q1 2021

May 07, 2021

SELL
$116.57 - $155.01 $147,577 - $196,242
-1,266 Reduced 64.1%
709 $93,000
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $6,773 - $9,664
68 Added 3.57%
1,975 $262,000
Q3 2020

Nov 09, 2020

BUY
$72.92 - $102.01 $119,005 - $166,480
1,632 Added 593.45%
1,907 $194,000
Q2 2020

Aug 05, 2020

BUY
$55.75 - $92.75 $4,627 - $7,698
83 Added 43.23%
275 $24,000
Q1 2020

May 05, 2020

BUY
$37.9 - $104.44 $3,107 - $8,564
82 Added 74.55%
192 $11,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $776 - $997
10 Added 10.0%
110 $10,000
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $2,982 - $4,042
-33 Reduced 24.81%
100 $9,000
Q2 2019

Aug 07, 2019

BUY
$89.51 - $118.04 $11,904 - $15,699
133 New
133 $16,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $96,276 - $142,009
-1,718 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $4,925 - $8,221
-102 Reduced 5.6%
1,718 $136,000
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $60,544 - $111,935
1,600 Added 727.27%
1,820 $109,000
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $35,006 - $45,564
-753 Reduced 77.39%
220 $12,000
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $3,371 - $4,287
91 Added 10.32%
973 $46,000
Q2 2017

Aug 11, 2017

BUY
N/A
882
882 $31,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.